Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran

Autor: Mehdi Bamorovat, Iraj Sharifi, Setareh Agha Kuchak Afshari, Ali Karamoozian, Amirhossein Tahmouresi, Amireh Heshmatkhah, Ehsan Salarkia, Ahmad Khosravi, Maryam Hakimi Parizi, Maryam Barghi

Publikováno v: International Journal for Parasitology: Drugs and Drug Resistance, Vol 21, Iss , Pp 21-27 (2023)

Leishmaniasis is an overlooked, poverty-stricken, and complex disease with growing social and public health problems. In general, leishmaniasis is a curable disease; however, there is an expansion of unresponsive cases to treatment in cutaneous leish

Externí odkaz: https://doaj.org/article/b2c7b2c56a9a4a4d9fa0bee74647d3a4

Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment

Autor: Mehdi Bamorovat, Iraj Sharifi, Mohammad Reza Aflatoonian, Ali Karamoozian, Amirhossein Tahmouresi, Abdollah Jafarzadeh, Amireh Heshmatkhah, Fatemeh Sharifi, Ehsan Salarkia, Tabandeh Khaleghi, Ahmad Khosravi, Maryam Nooshadokht, Mehdi Borhani Zarandi, Maryam Barghi

Publikováno v: International Journal of Infectious Diseases, Vol 122, Iss , Pp 155-161 (2022)

ABSTRACT: Introduction: We assessed the potential relationship between COVID-19 and laboratory-confirmed cutaneous leishmaniasis (CL)-registered cases with a history of scarring, compared with volunteer participants without history of CL. Methods: Th

Externí odkaz: https://doaj.org/article/dd8fbf743b3941a2bc510672d8a58097

Cutaneous Leishmaniasis Hampers COVID-19: A Controlled Cross-Sectional Study in High-Burden Endemic Areas of Iran.

Autor: Bamorovat M; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. mehdimorovat@ymail.com., Sharifi I; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. iraj.sharifi@yahoo.com., Shafiei Bafti M; Institute for Studies in Medicine History, Persian and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran.; Deputy for Health, Kerman University of Medical Sciences, Kerman, Iran., Agha Kuchak Afshari S; Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran., Aflatoonian MR; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran., Karamoozian A; Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Jafarzadeh A; Department of Immunology, Kerman University of Medical Sciences, Kerman, Iran., Amirzadeh R; Research Center for Social Determinants of Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Khosravi A; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran., Babaei Z; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran., Safa F; Deputy for Health, Kerman University of Medical Sciences, Kerman, Iran., Sharifi F; Research Center for Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran., Heshmatkhah A; Dadbin Health Clinic, Kerman University of Medical Sciences, Kerman, Iran.

Publikováno v: Journal of epidemiology and global health [J Epidemiol Glob Health] 2024 Mar; Vol. 14 (1), pp. 142-153. Date of Electronic Publication: 2024 Jan 08.

Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.

Autor: Mehdi Bamorovat, Iraj Sharifi, Shahriar Dabiri, Simin Shamsi Meymandi, Ali Karamoozian, Rezvan Amiri, Amireh Heshmatkhah, Mehdi Borhani Zarandi, Mohammad Reza Aflatoonian, Fatemeh Sharifi, Reza Kheirandish, Saeid Hassanzadeh

Publikováno v: PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0009089 (2021)

Over the last years, there has been a remarkable increase in the number of unresponsive patients with anthroponotic cutaneous leishmaniasis (ACL) reported worldwide. The primary objective of this study was to explore the role of demographic, clinical

Externí odkaz: https://doaj.org/article/cf34bdfd60e44ec1809d430ea21c67b5

Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.

Autor: Mohammad Reza Aflatoonian, Iraj Sharifi, Behnaz Aflatoonian, Mehdi Bamorovat, Amireh Heshmatkhah, Zahra Babaei, Pooya Ghasemi Nejad Almani, Mohammad Ali Mohammadi, Ehsan Salarkia, Abbas Aghaei Afshar, Hamid Sharifi, Fatemeh Sharifi, Ahmad Khosravi, Mehrdad Khatami, Nasir Arefinia, Alireza Fekri, Saeideh Farajzadeh, Ali Khamesipour, Mehdi Mohebali, Mohammad Mehdi Gouya, Mohammad Reza Shirzadi, Rajender S Varma

Publikováno v: PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007423 (2019)

BackgroundThe control of cutaneous leishmaniasis (CL) is facilitated by knowledge of factors associated with the treatment failures in endemic countries. The aim of this evaluation was to identify the potential risk determinants which might affect th

Externí odkaz: https://doaj.org/article/1f5175c231304665a1aa522210a13e2c